Cellogen Therapeutics: Financial Breakdown
Decoding financial health metrics of Cellogen Therapeutics
- Total Revenue₹46.1 Lakh305%
Prev. FY
- Total Expenses₹1.6 Cr168%
Prev. FY
- Profit After Tax₹-83.7 Lakh-159%
Prev. FY
- Total Assets₹13.3 Cr-4%
Prev. FY
FAQs on Financials of Cellogen Therapeutics
No. In FY25, Cellogen Therapeutics reported a net loss of ₹83.7 Lakh, so it was not profitable.
Cellogen Therapeutics's revenue grew 305.8% year-on-year, from ₹11.4 Lakh in FY24 to ₹46.1 Lakh in FY25.
In FY25, Cellogen Therapeutics posted revenue of ₹46.1 Lakh (up 305.8% YoY) and a net loss of ₹83.7 Lakh. Explore the full financials of Cellogen Therapeutics here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links

